AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Atovaquone

12 registrations across 1 African market— 7 active

Markets with Atovaquone

🇿🇦South Africa
12 registrations
7 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
ATOVAQUONE/PROGUANIL 250/100 mg GLENMARK🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveOct 2029
FALCIRONE🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
NUMAL🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
WELLVONE SUSPENSION🇿🇦South AfricaACINO PHARMA (PTY) LTDsuspendedDec 2023
ATAPRO 250/100 mg TABLET🇿🇦South AfricaSpecpharm (Pty) LtdsuspendedNov 2022
ATAPRO 62,5/25 mg PAEDIATRIC TABLET🇿🇦South AfricaSpecpharm (Pty) LtdsuspendedNov 2022
MOZITEC🇿🇦South AfricaActivo Health (Pty) LtdactiveJan 1900
HETOVANIL 250/100 mg🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
MALATEQ🇿🇦South AfricaForrester Pharma (Pty) LtdactiveJan 1900
MALANIL PAEDIATRIC🇿🇦South AfricaACINO PHARMA (PTY) LTDactiveJan 1900
MALANIL🇿🇦South AfricaACINO PHARMA (PTY) LTDactiveJan 1900
HETOVANIL 62,5/25 mg🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900

Atovaquone in Africa — Regulatory Overview

Atovaquone is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 7 (58%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.